| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/19/2007 | WO2007080874A1 Mutant gene fragment of glycopeptide-pooly-sensitive staphylococcus and use thereof |
| 07/19/2007 | WO2007080669A1 Antiviral/antiinflammatory drug composition |
| 07/19/2007 | WO2007080378A1 Use of morpholino compounds for the treatment of halitosis |
| 07/19/2007 | WO2007080010A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | WO2007079977A2 Nutraceutical compositions comprising tripeptides |
| 07/19/2007 | WO2006131326A3 Novel use of (-)-epigallocatechin gallate |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167500 Remedy for urinary tract diseases |
| 07/19/2007 | US20070167489 Combination comprising antimuscarinic agents and PDE4 inhibitors |
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167415 administering tetracycline derivatives such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline, thiatetracycline or 6-cyclopentylsulfanylmethyl doxycycline, to control parasitic infection and related disorders in a mammals |
| 07/19/2007 | US20070167403 Remedy for spinal canal stenosis |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166745 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/19/2007 | US20070166413 Cholestrol-reducing agent containing an n-3 fatty acid |
| 07/19/2007 | US20070166408 Composition and method to augment and sustain neurotransmitter production |
| 07/19/2007 | US20070166400 Pharmaceutical composition comprising i.a. vitamin c, magnesium green tea extract for retarding cardiovascular disease |
| 07/19/2007 | US20070166385 Method of inhibiting restenosis using bisphosphonates |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070166374 Orally administering edible oil homogenized with an edible wax and stigmasterol, campesterol, beta -sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and/or poriferasterol; repairing and promoting regeneration of mucosa in gastrointestinal tract |
| 07/19/2007 | US20070166370 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 07/19/2007 | US20070166363 Use of cholinesterase inhibitors for treating vascular depression |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | US20070166296 Therapeutic Systems |
| 07/19/2007 | US20070166280 Chemokines as adjuvants of immune response |
| 07/19/2007 | DE102006002164A1 Verfahren zur Unterdrückung endogener Oxidantien durch Stabilisierung mitochondrialer Membranen in der Behandlung aller Alterungsphänomene A method of suppressing endogenous oxidants by stabilization of mitochondrial membranes in the treatment of all aging phenomena |
| 07/19/2007 | CA2636618A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | CA2636333A1 Compositions and methods of treatment using modulators of motonueron diseases |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808177A2 Methods of treatment of mitochondrial disorders |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1808158A2 Presbyopia treatment by lens alteration |
| 07/18/2007 | EP1807435A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 07/18/2007 | EP1807419A1 (2-carboxamido)(3-amino) thiophene compounds |
| 07/18/2007 | EP1807086A1 Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases |
| 07/18/2007 | EP1807065A2 Methods and compositions for treating nephrogenic diabetes insipidus |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1284698B1 Method of pre-selecting a polymerizable fluid formed into an intraocular lens |
| 07/18/2007 | EP1181043B1 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 07/18/2007 | EP1178780B1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN1326522C Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 07/18/2007 | CN101001642A Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors |
| 07/18/2007 | CN101001639A Pegylation of vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase activating peptide (PACAP) receptor 2 (VPAC2) agonists and methods of use |
| 07/18/2007 | CN101001635A Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria |
| 07/18/2007 | CN101001609A Method of manufacturing pharmaceutical preparations containing liposomes |
| 07/18/2007 | CN100998870A Stable polymer micelle medicine carrging system |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998868A Antientity tumour composition |
| 07/18/2007 | CN100998867A Anticancer Chinese medicine compound nanometer emulsion and its preparation method |
| 07/18/2007 | CN100998591A Anticancer composition containing Epomycin and vasoinhibitor |
| 07/18/2007 | CN100998575A Finger nail coating agent of antifungal agent and its preparing method |
| 07/18/2007 | CN100998574A Capsule of anti-free radical agent for oral administration or external use and method for producing said capsule |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998555A Slow-release anticarcinogen containing vasoinhibitor |
| 07/18/2007 | CN100998554A Slow-release medicine for anti-solid tumor |
| 07/18/2007 | CN100998553A Compound anticarcinogen slow-release preparation containing vasoinhibitor |
| 07/17/2007 | USRE39734 Selenium source, a glutathione precursor of glutamic acid, cystine and glycine; increasing the content of glutathione in body tissue above that of a pretreatment level, enhancing immune activity |
| 07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
| 07/17/2007 | US7244756 For increasing blood-brain barrier permeability |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244749 Mixture of ascorbic acid, niacin, lysine and proline |
| 07/17/2007 | US7244742 Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| 07/17/2007 | US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244716 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244604 HDAC9 polypeptides and polynucleotides and uses thereof |
| 07/17/2007 | US7244449 Liposome-entrapped topoisomerase inhibitors |
| 07/17/2007 | US7244448 Providing liposome having free active agent and precipitated active agent encapsulated therein; varying amount of active agent that is precipitated in liposome for modulation plasma circulation half-life of active agent |
| 07/17/2007 | US7244443 Polymers of fluorinated monomers and hydrophilic monomers |
| 07/17/2007 | US7244438 Uses for polycationic compounds |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244426 Pharmaceutical compositions of fibrinolytic agent |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244414 Administering fine powder of active material; measured aerosol |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/12/2007 | WO2007079391A2 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 07/12/2007 | WO2007079389A2 Composition and method of use thereof |
| 07/12/2007 | WO2007079000A2 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy |
| 07/12/2007 | WO2007078874A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 07/12/2007 | WO2007077806A1 Pharmaceutical composition for application to nail |
| 07/12/2007 | WO2007077327A1 Association of a sinus current inhibitor if and a conversion enzyme inhibitor |
| 07/12/2007 | WO2007077164A1 New pharmaceutical compositions based on anticholinergics and andolast |